Bruce Greenberg serves as Executive at Aldeyra Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bruce Greenberg has executed 4 insider transactions totaling $141.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2024 involved selling 10,834 shares valued at $51.4K.
Bruce Greenberg currently holds 126,382 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Greenberg has been a net seller of ALDX stock. They have purchased $0 and sold $141.4K worth of shares.
Bruce Greenberg's most recent insider trade was on Aug 12, 2024, when they sold 10,834 shares at $4.74 per share.
Get notified when new Form 4 filings are submitted
| $3.41 |
| Discretionary |
| Mar 11, 2024 | ALDX | $45.0K | Sale | 13,201 | $3.41 | Discretionary |
| Jul 15, 2022 | ALDX | $0 | Award | 126,087 | $N/A | Discretionary |